Location of the GLP-1R population plays an essential role in satiating versus aversive effects of GLP-1R agonists ( Figure 3 )
More than medication You are not just getting medication
A meta-analysis has indeed highlighted that only about 5060% of patients with diabetes adhere to antidiabetic therapy [69], with a significant impact on quality of life and life expectancy
Optimising GLP-1/GIP targeting for individual patients We are currently working to clarify how exactly each receptor works by investigating how they move across the cells of the pancreas, the signals they send, and the partners they interact with
How Common are These Reactions, and How Worried Should You Be
Similarly, coaching tools that provide personalized, daily recommendations on food choices and lifestyle to augment the support of 1:1 coaching present a scalable, impactful opportunity